Losartan Potassium and HCTZ Tablets Recalled for AZIDO Impurity Deviations
Preferred Pharmaceuticals is recalling specific lots of Losartan Potassium & HCTZ Tablets due to AZIDO impurity levels exceeding acceptable manufacturing standards. The recalled tablets were distributed in Florida and California.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II pharmaceutical recall involving impurity levels above acceptable manufacturing standards. This represents a risk-of-harm product where injury has not been reported, meeting the High (3) severity criterion.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling specific lots of Losartan Potassium & HCTZ Tablets 50mg/12.5 mg due to current good manufacturing practice (CGMP) deviations. Testing detected AZIDO impurity levels above acceptable limits in the affected product.
The recall affects two lot numbers: K1721E (47 bottles, expiration 4/30/2023) and H3021Q (35 bottles, expiration 2/28/2023). These tablets were distributed in Florida and California.
Consumers in possession of the affected lots should discontinue use and contact their healthcare provider or pharmacist for instructions on obtaining replacement medication.
The recalled product
- Product
- Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5 mg, Pkg Size: 30, NDC: 68788-7758-03.
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot: K1721E
- EXP: 4/30/2023
- NDC: 68788-7758-03
- Lot: H3021Q
- EXP: 2/28/2023
- NDC: 68788-7758-03.
Distribution
Part of a larger recall action
This product is one of 2 recalled by Preferred Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Preferred Pharmaceuticals, Inc.
See all →- HighGeri-Care artificial tears lubricant eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- ModerateOndansetron blister packs recalled because tablets are falling out
FDA (Drugs) · 2025-12-24
- ModerateClindamycin Hydrochloride Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-07
- HighIbuprofen Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-09-04
- HighDuloxetine Delayed-Release Capsules Recalled for Nitrosamine Impurity
FDA (Drugs) · 2024-05-29
Same hazard · azido impurity
See all →- HighLosartan Potassium Tablets Recalled for Elevated AZIDO Impurity Levels
FDA (Drugs) · 2022-07-06
- HighFDA Recalls Losartan-Hydrochlorothiazide Tablets for Manufacturing Quality Deviations
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium Tablets Recalled for Manufacturing Impurity Issues
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium tablets recalled for elevated AZIDO impurity
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium Tablets Recalled for CGMP Deviations and Elevated Impurity
FDA (Drugs) · 2022-06-08